David Dahlgren - Concepedia

Author

David Dahlgren

Uppsala University ORCID

Also Known As

D Dahlgren, D. Dahlgren, David Dahlgren

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Uppsala University AstraZeneca (Sweden)Swedish Veterinary Agency Universitat de València Johannes Gutenberg University Mainz

About

David Dahlgren is an author at Uppsala University specializing in pharmacology, medicine, and gastroenterology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	304
2	Engineering	1	1	26
3	Social Sciences	1	1	32
4	Biochemistry	1	1	23
5	Biomedical Engineering	1	1	26

David Dahlgren

Publications

735

Citations

H-Index

Page 1

	Year	Citations
Regional Intestinal Permeability of Three Model Drugs in Human David Dahlgren, Carl Roos, Anders Lundqvist, Molecular Pharmaceutics Gastrointestinal PharmacologyMedian PeffGastroenterologyThree Model DrugsDigestive Tract	2016	67
Human<i>in Vivo</i>Regional Intestinal Permeability: Quantitation Using Site-Specific Drug Absorption Data Erik Sjögren, David Dahlgren, Carl Roos, Molecular Pharmaceutics	2015	63
Fasted and fed state human duodenal fluids: Characterization, drug solubility, and comparison to simulated fluids and with human bioavailability David Dahlgren, Márta Venczel, J.-P. Ridoux, European Journal of Pharmaceutics and Biopharmaceutics	2021	57
<i>In Vivo</i> Mechanisms of Intestinal Drug Absorption from Aprepitant Nanoformulations Carl Roos, David Dahlgren, Staffan Berg, Molecular Pharmaceutics	2017	56
The effects of three absorption-modifying critical excipients on the in vivo intestinal absorption of six model compounds in rats and dogs David Dahlgren, Christian Roos, Pernilla Johansson, International Journal of Pharmaceutics Absorption-modifying Critical ExcipientsGastrointestinal PharmacologyMedicinePhysiologyFood Digestion	2018	50
Regional Intestinal Permeability in Rats: A Comparison of Methods Carl Roos, David Dahlgren, Erik Sjögren, Molecular Pharmaceutics	2017	48
Regional Intestinal Permeability in Dogs: Biopharmaceutical Aspects for Development of Oral Modified-Release Dosage Forms David Dahlgren, Carl Roos, Pernilla Johansson, Molecular Pharmaceutics Li AbsorptionGastrointestinal PharmacologyGastroenterologyDigestive TractPharmacodynamic Modeling	2016	35
Preclinical Effect of Absorption Modifying Excipients on Rat Intestinal Transport of Model Compounds and the Mucosal Barrier Marker<sup>51</sup>Cr-EDTA David Dahlgren, Carl Roos, Anders Lundqvist, Molecular Pharmaceutics	2017	34
Effect of absorption-modifying excipients, hypotonicity, and enteric neural activity in an in vivo model for small intestinal transport David Dahlgren, Christian Roos, Anders Lundqvist, International Journal of Pharmaceutics NeurophysiologyMedicineFood DigestionPhysiologyGastroenterology	2018	32
Evaluation of drug permeability calculation based on luminal disappearance and plasma appearance in the rat single-pass intestinal perfusion model David Dahlgren, Christian Roos, Karsten Peters, European Journal of Pharmaceutics and Biopharmaceutics Drug Permeability CalculationPlasma AppearanceLuminal DisappearanceMedicinePhysiology	2019	27

Page 1